Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Clostridium difficile and Clostridium perfringens research, Microscopic Colitis, Nosocomial Infections in ICU, and Gut microbiota and health.
Faecal microbiota transplant to ERadicate gastrointestinal carriage of Antibiotic-Resistant Organisms (FERARO): A feasibility randomised controlled trial
Limitations of current techniques in clinical antimicrobial resistance diagnosis: examples and future prospects
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
Unified metagenomic method for rapid detection of microorganisms in clinical samples
The use of faecal microbiota transplant as treatment for recurrent or refractory<i>Clostridioides difficile</i>infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
The drainome: longitudinal metagenomic characterization of wastewater from hospital ward sinks to characterize the microbiome and resistome and to assess the effects of decontamination interventions
The ongoing Streptococcus pyogenes (Group A Streptococcus) outbreak in London, United Kingdom, in December 2022: a molecular epidemiology study
Routine Metagenomics Service for ICU Patients with Respiratory Infection
Modulation of the Gut Microbiota to Control Antimicrobial Resistance (AMR)—A Narrative Review with a Focus on Faecal Microbiota Transplantation (FMT)
Design and manufacture of a lyophilised faecal microbiota capsule formulation to GMP standards
The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey
Regulation, risk and safety of Faecal Microbiota Transplant
A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group
Detecting SARS-CoV-2 at point of care: preliminary data comparing loop-mediated isothermal amplification (LAMP) to polymerase chain reaction (PCR)
Individual- and community-level risk factors for ESBL Enterobacteriaceae colonization identified by universal admission screening in London
PROFIT, a PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis: study protocol for a single-blinded trial
The use of faecal microbiota transplant as treatment for recurrent or refractory<i>Clostridium difficile</i>infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
Comparison of Different Strategies for Providing Fecal Microbiota Transplantation to Treat Patients with Recurrent Clostridium difficile Infection in Two English Hospitals: A Review
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients aged ≥60 years (EXTEND): analysis of cost-effectiveness
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial
Microbiological problems and biofilms associated with Mycobacterium chimaera in heater–cooler units used for cardiopulmonary bypass
Point‐of‐care tests for infectious diseases: barriers to implementation across three London teaching hospitals
Evidence for Community Transmission of Community-Associated but Not Health-Care-Associated Methicillin-Resistant Staphylococcus Aureus Strains Linked to Social and Material Deprivation: Spatial Analysis of Cross-sectional Data
Universal hospital admission screening for carbapenemase-producing organisms in a low-prevalence setting
The projected effectiveness of Clostridium difficile vaccination as part of an integrated infection control strategy
Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination
The impact of the introduction of fidaxomicin on the management of Clostridium difficile infection in seven NHS secondary care hospitals in England: a series of local service evaluations
Reduction in Clostridium difficile environmental contamination by hospitalized patients treated with fidaxomicin
<b>Contamination</b> of the Hospital Environment From Potential <i>Clostridium difficile</i> Excretors Without Active Infection